冥想应用程序减少焦虑和改善身心健康的随机对照试验方案摘要
本研究为随机对照试验,计划纳入约150名美国成年人,比较每日使用冥想应用程序30天与不使用对焦虑和幸福感的影响。主要结局为基于GAD7和WHO-5的问卷评分,采用开放标签设计,分配比例1:1。
要点
- 每日使用冥想应用程序10分钟,持续30天,对照组不使用。
- 主要结局为焦虑(GAD7改编问卷)和幸福感(WHO-5改编问卷)评分变化。
- 试验为开放标签、平行对照设计,计划每组约75人。
核心结论
- 该方案旨在评估每日使用冥想应用程序30天对COVID-19大流行期间成人焦虑和幸福感的干预效果,目前尚未报告结果。
研究设计与样本
- 随机对照试验,平行分配,1:1分配比例,区组大小为8。
- 计划随机化约150名参与者,每组约75人。
- 纳入标准:18岁及以上、拥有智能手机、英语流利、能独立完成调查、研究期间在美国。
- 排除标准:当前定期使用正念或冥想应用程序、定期练习正念或冥想、定期治疗、无法独立完成调查或存在妨碍参与的心理健康限制。
- 开放标签设计,无设盲。
关键数值与推荐
- 干预组每日使用Insight Timer应用程序10分钟,持续30天;对照组不使用任何正念应用程序。
- 主要结局为焦虑(基于GAD7改编的问卷问题)和幸福感(基于WHO-5改编的问卷问题),比较干预前与30天干预后的变化。
- 干预结束后两个月进行另一次后干预调查。
局限性
- 开放标签设计,无设盲,可能存在偏倚。
- 样本量有限(计划约150人),且仅纳入美国英语使用者,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This interventional study will investigate the effect of daily use of a mindfulness app on measures of participant anxiety, well-being, and perceived outlook during the COVID-19 pandemic, by comparing pre-intervention survey responses to post-intervention survey responses. TRIAL DESIGN: Randomized, controlled trial with parallel assignment. Adults will be assigned either to daily use of a meditation app for 30 days or to a control group (no usage of meditation app) with a 1:1 equivalence allocation ratio. PARTICIPANTS: Inclusion Criteria: Participants must be 18 or older, have a smartphone, able to download apps to their smartphone, must be fluent in the English language, able to complete surveys on their own, and must be in the United States for the duration of the study. EXCLUSION CRITERIA: Current regular use of a mindfulness or meditation app, regular practice of mindfulness or meditation, regular therapy sessions, inability to complete surveys independently, or any mental health restrictions that would prevent participation. All data will be collected through the Insight Timer Meditation App and Google Forms. This trial is being conducted through the Lake Erie College of Osteopathic Medicine in Erie, PA, with all data collected digitally. INTERVENTION AND COMPARATOR: Intervention: Participants will be sent a link to a pre-intervention survey prior to first use of the mindfulness app. Participants will be instructed to use the Insight Timer app for 10 minutes daily for 30 days. At the end of the 30-day intervention period, participants will be sent a link for the post-intervention survey. Two months after the conclusion of the 30-day intervention period, participants will be sent a link for another post-intervention survey. Comparator: Participants will receive the same surveys, but will not use any mindfulness app for the 30-day intervention period. After this 30-day period, participants are invited to use the Insight Timer app if they so choose. MAIN OUTCOMES: The main outcomes are (1) anxiety as assessed by survey questions adapted from the GAD7, comparing pre-intervention to post-30-days of app usage and (2) well-being as assessed by survey questions adapted from the WHO-5, comparing pre-intervention and post-30-days of app usage. RANDOMIZATION: Participants will be allocated to interventions via a block random sequence generator with a 1:1 allocation ratio in blocks of 8. BLINDING (MASKING): No masking is being used in this study (open label). NUMBERS TO BE RANDOMIZED (SAMPLE SIZE): Approximately 75 participants will be randomized to each group, with an estimated enrollment of 150 participants. TRIAL STATUS: This study is protocol version number 27-126 and was approved on May 10, 2020. Recruitment began on August 19, 2020 and will end February 28, 2021. The study is estimated to complete on April 30, 2021. TRIAL REGISTRATION: This trial was registered to ClinicalTrials.gov on 30 April 2020. The ClinicalTrials.gov Identifier is NCT04369378 . FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional File 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.
引用
- O'Donnell KT, Dunbar M, Speelman DL, et al. Effectiveness of using a meditation app in reducing anxiety and improving well-being during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020. PMID: 33298117. doi:10.1186/s13063-020-04935-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。